Compare LFMD & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFMD | ETON |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.5M | 498.8M |
| IPO Year | N/A | 2018 |
| Metric | LFMD | ETON |
|---|---|---|
| Price | $3.28 | $16.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $10.22 | ★ $29.67 |
| AVG Volume (30 Days) | ★ 1.1M | 267.4K |
| Earning Date | 11-17-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $250,091,814.00 | $70,316,000.00 |
| Revenue This Year | $13.65 | $113.27 |
| Revenue Next Year | N/A | $36.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 28.78 | ★ 102.77 |
| 52 Week Low | $3.21 | $11.09 |
| 52 Week High | $15.84 | $23.00 |
| Indicator | LFMD | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 47.14 |
| Support Level | $3.21 | $15.75 |
| Resistance Level | $3.45 | $17.19 |
| Average True Range (ATR) | 0.18 | 0.70 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 2.36 | 55.03 |
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.